Gray, Heidi J.
Chatterjee, Payel
Rosati, Rachele
Appleyard, Lauren R.
Durenberger, Grace J.
Diaz, Robert L.
Swan, Hallie A.
Peretti, Danielle
Pollastro, Maddy
Ainge, Trevor
Kapeli, Katannya
Pereira, Shalini
Margossian, Astrid L.
Banda, Kalyan
Goff, Barbara A. https://orcid.org/0000-0003-0153-5544
Swisher, Elizabeth M.
Bernard, Brady
Kemp, Christopher J.
Grandori, Carla https://orcid.org/0000-0001-9109-410X
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U01 CA217883, R01 CA214428)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 27 September 2022
Accepted: 18 April 2023
First Online: 18 May 2023
Competing interests
: P.C., A.T., R.R., L.R.K., G.J.D., R.D., H.A.S., D.P., M.P., K.K., B.B., S.P., A.M. and C.G. are or were at the time of the study employees at SEngine and received stock options from the company. C.J.K. is a founder and stockholder in SEngine. The remaining authors declare no competing interests.